EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

NAT10-mediated ac4C tRNA modification promotes EGFR mRNA translation and gefitinib resistance in cancer

Wei Wei, Shuishen Zhang, Hui Han, Xiaochen Wang, Siyi Zheng, Zhaoyu Wang, Chunlong Yang, Lu Wang, Jieyi Ma, Siyao Guo, Juan Wang, Lianlian Liu und 2 weitere

Cell Reports · 2023-07 · 42 (7) · 112810

DOI: 10.1016/j.celrep.2023.112810 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell Reports, 2023-07. Verfasst von Wei Wei und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology, Center for Translational Medicine, Precision Medicine Institute, The First Affiliated Hospital of Sun Yat-sen Universit…. Hauptthemen laut MEDLINE: Neoplasms, RNA, Transfer, N-Terminal Acetyltransferases. Die Arbeit wurde bisher 90-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Fundamental Research Funds for the Central Universities, National Natural Science Foundation of China, Sun Yat-sen University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeoplasmsRNA, TransferN-Terminal AcetyltransferasesAnimalsMiceErbB ReceptorsGefitinibProtein BiosynthesisHumansCell Line, TumorDrug Resistance, Neoplasm

Stichwörter der Autor:innen

CP: CancerEGFRN4-acetylcytidineNAT10esophageal cancertRNA modificatio

Substanzen

ErbB ReceptorsGefitinibRNA, TransferNAT10 protein, humanN-Terminal Acetyltransferases

Autor:innen und Institutionen

  • Department of Otolaryngology, Center for Translational Medicine, Precision Medicine Institute, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou 510080, China.
  • Department of Thoracic Surgery, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou 510080, China.
  • Clinical Research Center, Affiliated Hospital of Guangdong Medical University, Zhanjiang 524001, China.
  • Department of Medical Laboratory, School of Laboratory Medicine and Biotechnology, Southern Medical University, Guangzhou 510515, China.
  • Division of Pulmonary and Critical Care Medicine, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou 510080, China.
  • Department of Oral and Maxillofacial Surgery, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou 510080, China.

Förderung

  • Fundamental Research Funds for the Central Universities
  • National Natural Science Foundation of China
  • Sun Yat-sen University
  • Natural Science Foundation of Guangdong Province
  • National Key Research and Development Program of China

Zitieren

APA

Wei, W., Zhang, S., Han, H., Wang, X., Zheng, S., Wang, Z., Yang, C., Wang, L., Ma, J., Guo, S., Wang, J., Liu, L., Choe, J., & Lin, S. (2023). NAT10-mediated ac4C tRNA modification promotes EGFR mRNA translation and gefitinib resistance in cancer. Cell Reports, 42(7), 112810. https://doi.org/10.1016/j.celrep.2023.112810

Vancouver

Wei W, Zhang S, Han H, Wang X, Zheng S, Wang Z, et al. NAT10-mediated ac4C tRNA modification promotes EGFR mRNA translation and gefitinib resistance in cancer. Cell Reports. 2023;42(7):112810. doi:10.1016/j.celrep.2023.112810

BibTeX
@article{Wei2023,
  author = {Wei, Wei and Zhang, Shuishen and Han, Hui and Wang, Xiaochen and Zheng, Siyi and Wang, Zhaoyu and Yang, Chunlong and Wang, Lu and Ma, Jieyi and Guo, Siyao and Wang, Juan and Liu, Lianlian and Choe, Junho and Lin, Shuibin},
  title = {NAT10-mediated ac4C tRNA modification promotes EGFR mRNA translation and gefitinib resistance in cancer},
  journal = {Cell Reports},
  year = {2023},
  volume = {42},
  number = {7},
  pages = {112810},
  doi = {10.1016/j.celrep.2023.112810}
}
Kostenlos starten →